Vyome Holdings, Inc SEC filings HIND

Vyome Holdings, Inc has 693 filings in SEC EDGAR's recent list, going back to Feb 13, 2008. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 28, 2026 (officer or director change). The company's fiscal year ends on December 31.

Vyome Holdings, Inc SEC filings
Form Description Filed Period
424B3 Prospectus Nov 26, 2025 —
S-8 Employee stock plan registration Nov 13, 2025 —
S-3 Shelf registration Nov 6, 2025 —
424B5 Prospectus supplement Aug 20, 2025 —
424B3 Prospectus Jun 24, 2025 —
POS AM Filing Jun 17, 2025 —
424B5 Prospectus supplement Jun 9, 2025 —
424B3 Prospectus Jun 6, 2025 —
424B5 Prospectus supplement May 30, 2025 —
S-4/A Filing May 14, 2025 —
S-3 Shelf registration May 9, 2025 —
S-4/A Form s-4/a May 9, 2025 —
S-4/A Form s-4/a Apr 29, 2025 —
424B3 Prospectus Feb 18, 2025 —
S-1MEF Filing Feb 14, 2025 —
424B3 Prospectus Feb 14, 2025 —
S-1/A Amended registration statement Feb 14, 2025 —
S-1/A Amended registration statement Feb 14, 2025 —
S-1/A Amended registration statement Feb 13, 2025 —
S-1/A Amended registration statement Feb 7, 2025 —
S-1/A Amended registration statement Feb 6, 2025 —
S-1 Registration statement Jan 21, 2025 —
S-4/A Filing Jan 15, 2025 —
S-1/A Amended registration statement Jan 15, 2025 —
S-1 Registration statement Dec 20, 2024 —
S-4/A Form s-4/a Dec 6, 2024 —
S-4 Registration for a merger or exchange Oct 1, 2024 —
S-3 Shelf registration May 9, 2024 —
424B4 Prospectus Oct 3, 2023 —
S-1/A Amended registration statement Sep 27, 2023 —
S-1/A Amended registration statement Sep 12, 2023 —
S-1 Registration statement Aug 25, 2023 —
S-8 Employee stock plan registration Jun 23, 2023 —
424B5 Prospectus supplement Apr 24, 2023 —
424B4 Prospectus Feb 8, 2023 —
S-1MEF Filing Feb 3, 2023 —
S-1/A Amended registration statement Feb 3, 2023 —
S-1/A Amended registration statement Feb 2, 2023 —
S-1/A Amended registration statement Jan 27, 2023 —
S-1 Registration statement Jan 12, 2023 —
424B5 Prospectus supplement Nov 9, 2022 —
424B3 Prospectus Sep 21, 2021 —
S-3 Shelf registration Sep 3, 2021 —
S-3 Shelf registration Sep 3, 2021 —
424B3 Prospectus Apr 13, 2021 —
S-4/A Filing Apr 9, 2021 —
S-4 Registration for a merger or exchange Mar 30, 2021 —
S-8 Employee stock plan registration Feb 3, 2021 —
424B3 Prospectus Feb 28, 2020 —
S-1 Registration statement Feb 7, 2020 —
S-8 Employee stock plan registration Jan 24, 2020 —
S-8 Employee stock plan registration Jan 10, 2020 —
424B4 Prospectus Aug 5, 2019 —
S-1/A Amended registration statement Aug 1, 2019 —
S-1/A Amended registration statement Jul 30, 2019 —
FWP Free writing prospectus Jul 26, 2019 —
S-1/A Amended registration statement Jul 26, 2019 —
S-8 Employee stock plan registration Jul 22, 2019 —
S-1 Registration statement Jun 21, 2019 —
424B5 Prospectus supplement Jun 7, 2019 —
424B5 Prospectus supplement May 28, 2019 —
424B3 Prospectus Feb 22, 2019 —
S-1/A Amended registration statement Feb 11, 2019 —
S-1 Registration statement Jan 4, 2019 —
FWP Free writing prospectus Dec 27, 2018 —
424B5 Prospectus supplement Dec 27, 2018 —
424B3 Prospectus Sep 17, 2018 —
S-3 Shelf registration Aug 31, 2018 —
S-8 Employee stock plan registration May 11, 2018 —
424B5 Prospectus supplement Jan 22, 2018 —
424B5 Prospectus supplement Jan 16, 2018 —
S-3/A Filing Nov 17, 2017 —
S-3 Shelf registration Nov 1, 2017 —
S-8 Employee stock plan registration Jun 2, 2017 —
424B4 Prospectus Oct 6, 2016 —
S-8 Employee stock plan registration Oct 6, 2016 —
S-1/A Amended registration statement Sep 26, 2016 —
S-1 Registration statement Sep 9, 2016 —

Showing 78 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
HIND (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Clemente, CA
SEC filer status
, Emerging growth company
SEC CIK
1427570
Former names
ReShape Lifesciences Inc. (until Aug 14, 2025); OBALON THERAPEUTICS INC (until Jun 21, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.